Headlines from the Proactive UK newsroom.
Smiths Group (LON:SMIN) has halted the planned demerger of its medical arm due to the coronavirus crisis. Smiths Medical needs to concentrate on the delivery of ventilators and other critical care devices, though the intention remains to separate once the crisis passes.
American Airlines is to ask the US government for US$12bn to help it keep flying through all potential future scenarios. Several UK airlines are expected to ask for a bailout from the government here this week.
Verona Pharma (LON:VRP) has reported encouraging signs of efficacy in a phase II trial of a single dose of its COPD treatment ensifentrine. Statistically significant improvements in lung function were observed in the 40 patients.
88 Energy’s (LON:88E) Charlie-1 well in Alaska encountered ‘shows’ and ‘elevated log responses’ over several horizons on its way to target depth. The logging data to date is “largely consistent” the company says with that recorded at the Malguk-1 well drilled by BP in 1991.
And Synairgen (LON:SNG) has started dosing patients in its trial of an interferon-beta treatment in coronavirus patients. The first patient was at the University Hospital Southampton with a further six trial sites expected to start dosing shortly.